Atlas Trials

Proof of Concept Study to Evaluate the Safety Profile of Plitidepsin in Patients With COVID-19

Clinical trial NCT04382066 · COMPLETED

Trial details

NCT number
NCT04382066
Sponsor
PharmaMar
Status
COMPLETED
Phase
Phase 1
Study type
INTERVENTIONAL
COVID-19
Start date
2020-05-12
Primary completion
2020-11-26
Enrollment
46

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.